List of Tables
Table 1. Global Restless Legs Syndrome Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Pharmacological Therapy
Table 3. Key Players of Non-Pharmacological Therapy
Table 4. Global Restless Legs Syndrome Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 5. Global Restless Legs Syndrome Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Restless Legs Syndrome Market Size by Region (US$ Million), 2021–2026
Table 7. Global Restless Legs Syndrome Market Share by Region (2021–2026)
Table 8. Global Restless Legs Syndrome Forecasted Market Size by Region (US$ Million), 2027–2032
Table 9. Global Restless Legs Syndrome Market Share by Region (2027–2032)
Table 10. Restless Legs Syndrome Market Trends
Table 11. Restless Legs Syndrome Market Drivers
Table 12. Restless Legs Syndrome Market Challenges
Table 13. Restless Legs Syndrome Market Restraints
Table 14. Global Restless Legs Syndrome Revenue by Players (US$ Million), 2021–2026
Table 15. Global Restless Legs Syndrome Market Share by Players (2021–2026)
Table 16. Global Top Restless Legs Syndrome Players by Tier (Tier 1, Tier 2, and Tier 3), based on Restless Legs Syndrome Revenue, 2025
Table 17. Ranking of Global Top Restless Legs Syndrome Companies by Revenue (US$ Million) in 2025
Table 18. Global 5 Largest Players Market Share by Restless Legs Syndrome Revenue (CR5 and HHI), 2021–2026
Table 19. Global Key Players of Restless Legs Syndrome, Headquarters and Area Served
Table 20. Global Key Players of Restless Legs Syndrome, Products and Applications
Table 21. Global Key Players of Restless Legs Syndrome, Date of General Availability (GA)
Table 22. Mergers and Acquisitions, Expansion Plans
Table 23. Global Restless Legs Syndrome Market Size by Type (US$ Million), 2021–2026
Table 24. Global Restless Legs Syndrome Revenue Market Share by Type (2021–2026)
Table 25. Global Restless Legs Syndrome Forecasted Market Size by Type (US$ Million), 2027–2032
Table 26. Global Restless Legs Syndrome Revenue Market Share by Type (2027–2032)
Table 27. Global Restless Legs Syndrome Market Size by Application (US$ Million), 2021–2026
Table 28. Global Restless Legs Syndrome Revenue Market Share by Application (2021–2026)
Table 29. Global Restless Legs Syndrome Forecasted Market Size by Application (US$ Million), 2027–2032
Table 30. Global Restless Legs Syndrome Revenue Market Share by Application (2027–2032)
Table 31. North America Restless Legs Syndrome Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 32. North America Restless Legs Syndrome Market Size by Country (US$ Million), 2021–2026
Table 33. North America Restless Legs Syndrome Market Size by Country (US$ Million), 2027–2032
Table 34. Europe Restless Legs Syndrome Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. Europe Restless Legs Syndrome Market Size by Country (US$ Million), 2021–2026
Table 36. Europe Restless Legs Syndrome Market Size by Country (US$ Million), 2027–2032
Table 37. Asia-Pacific Restless Legs Syndrome Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 38. Asia-Pacific Restless Legs Syndrome Market Size by Region (US$ Million), 2021–2026
Table 39. Asia-Pacific Restless Legs Syndrome Market Size by Region (US$ Million), 2027–2032
Table 40. Latin America Restless Legs Syndrome Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. Latin America Restless Legs Syndrome Market Size by Country (US$ Million), 2021–2026
Table 42. Latin America Restless Legs Syndrome Market Size by Country (US$ Million), 2027–2032
Table 43. Middle East & Africa Restless Legs Syndrome Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Middle East & Africa Restless Legs Syndrome Market Size by Country (US$ Million), 2021–2026
Table 45. Middle East & Africa Restless Legs Syndrome Market Size by Country (US$ Million), 2027–2032
Table 46. Boehringer Ingelheim GmbH Company Details
Table 47. Boehringer Ingelheim GmbH Business Overview
Table 48. Boehringer Ingelheim GmbH Restless Legs Syndrome Product
Table 49. Boehringer Ingelheim GmbH Revenue in Restless Legs Syndrome Business (US$ Million), 2021–2026
Table 50. Boehringer Ingelheim GmbH Recent Development
Table 51. UCB SA Company Details
Table 52. UCB SA Business Overview
Table 53. UCB SA Restless Legs Syndrome Product
Table 54. UCB SA Revenue in Restless Legs Syndrome Business (US$ Million), 2021–2026
Table 55. UCB SA Recent Development
Table 56. Astellas Company Details
Table 57. Astellas Business Overview
Table 58. Astellas Restless Legs Syndrome Product
Table 59. Astellas Revenue in Restless Legs Syndrome Business (US$ Million), 2021–2026
Table 60. Astellas Recent Development
Table 61. Arbor Pharmaceuticals Company Details
Table 62. Arbor Pharmaceuticals Business Overview
Table 63. Arbor Pharmaceuticals Restless Legs Syndrome Product
Table 64. Arbor Pharmaceuticals Revenue in Restless Legs Syndrome Business (US$ Million), 2021–2026
Table 65. Arbor Pharmaceuticals Recent Development
Table 66. GlaxoSmithKline plc. Company Details
Table 67. GlaxoSmithKline plc. Business Overview
Table 68. GlaxoSmithKline plc. Restless Legs Syndrome Product
Table 69. GlaxoSmithKline plc. Revenue in Restless Legs Syndrome Business (US$ Million), 2021–2026
Table 70. GlaxoSmithKline plc. Recent Development
Table 71. Ligand Pharmaceuticals Incorporated Company Details
Table 72. Ligand Pharmaceuticals Incorporated Business Overview
Table 73. Ligand Pharmaceuticals Incorporated Restless Legs Syndrome Product
Table 74. Ligand Pharmaceuticals Incorporated Revenue in Restless Legs Syndrome Business (US$ Million), 2021–2026
Table 75. Ligand Pharmaceuticals Incorporated Recent Development
Table 76. axxonis Pharma AG Company Details
Table 77. axxonis Pharma AG Business Overview
Table 78. axxonis Pharma AG Restless Legs Syndrome Product
Table 79. axxonis Pharma AG Revenue in Restless Legs Syndrome Business (US$ Million), 2021–2026
Table 80. axxonis Pharma AG Recent Development
Table 81. Kyowa Hakko Kirin Co. Company Details
Table 82. Kyowa Hakko Kirin Co. Business Overview
Table 83. Kyowa Hakko Kirin Co. Restless Legs Syndrome Product
Table 84. Kyowa Hakko Kirin Co. Revenue in Restless Legs Syndrome Business (US$ Million), 2021–2026
Table 85. Kyowa Hakko Kirin Co. Recent Development
Table 86. Jazz Pharmaceuticals, Inc. Company Details
Table 87. Jazz Pharmaceuticals, Inc. Business Overview
Table 88. Jazz Pharmaceuticals, Inc. Restless Legs Syndrome Product
Table 89. Jazz Pharmaceuticals, Inc. Revenue in Restless Legs Syndrome Business (US$ Million), 2021–2026
Table 90. Jazz Pharmaceuticals, Inc. Recent Development
Table 91. Omeros Corporation Company Details
Table 92. Omeros Corporation Business Overview
Table 93. Omeros Corporation Restless Legs Syndrome Product
Table 94. Omeros Corporation Revenue in Restless Legs Syndrome Business (US$ Million), 2021–2026
Table 95. Omeros Corporation Recent Development
Table 96. Manhattan Pharmaceuticals Company Details
Table 97. Manhattan Pharmaceuticals Business Overview
Table 98. Manhattan Pharmaceuticals Restless Legs Syndrome Product
Table 99. Manhattan Pharmaceuticals Revenue in Restless Legs Syndrome Business (US$ Million), 2021–2026
Table 100. Manhattan Pharmaceuticals Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
Table 104. Authors List of This Report
List of Figures
Figure 1. Restless Legs Syndrome Picture
Figure 2. Global Restless Legs Syndrome Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Restless Legs Syndrome Market Share by Type: 2025 vs 2032
Figure 4. Pharmacological Therapy Features
Figure 5. Non-Pharmacological Therapy Features
Figure 6. Global Restless Legs Syndrome Market Size by Application (US$ Million), 2021–2032
Figure 7. Global Restless Legs Syndrome Market Share by Application: 2025 vs 2032
Figure 8. Below 35 Years Old Case Studies
Figure 9. From 35 to 50 Years Old Case Studies
Figure 10. Above 50 Years Old Case Studies
Figure 11. Restless Legs Syndrome Report Years Considered
Figure 12. Global Restless Legs Syndrome Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 13. Global Restless Legs Syndrome Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Restless Legs Syndrome Market Share by Region: 2025 vs 2032
Figure 15. Global Restless Legs Syndrome Market Share by Players in 2025
Figure 16. Global Restless Legs Syndrome Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 17. The Top 10 and 5 Players Market Share by Restless Legs Syndrome Revenue in 2025
Figure 18. North America Restless Legs Syndrome Market Size YoY Growth (US$ Million), 2021–2032
Figure 19. North America Restless Legs Syndrome Market Share by Country (2021–2032)
Figure 20. United States Restless Legs Syndrome Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. Canada Restless Legs Syndrome Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Europe Restless Legs Syndrome Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Restless Legs Syndrome Market Share by Country (2021–2032)
Figure 24. Germany Restless Legs Syndrome Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. France Restless Legs Syndrome Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. U.K. Restless Legs Syndrome Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Italy Restless Legs Syndrome Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Russia Restless Legs Syndrome Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Ireland Restless Legs Syndrome Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Asia-Pacific Restless Legs Syndrome Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Restless Legs Syndrome Market Share by Region (2021–2032)
Figure 32. China Restless Legs Syndrome Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Japan Restless Legs Syndrome Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. South Korea Restless Legs Syndrome Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Southeast Asia Restless Legs Syndrome Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. India Restless Legs Syndrome Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Australia & New Zealand Restless Legs Syndrome Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Latin America Restless Legs Syndrome Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Restless Legs Syndrome Market Share by Country (2021–2032)
Figure 40. Mexico Restless Legs Syndrome Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Brazil Restless Legs Syndrome Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Middle East & Africa Restless Legs Syndrome Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Restless Legs Syndrome Market Share by Country (2021–2032)
Figure 44. Israel Restless Legs Syndrome Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Saudi Arabia Restless Legs Syndrome Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. UAE Restless Legs Syndrome Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Boehringer Ingelheim GmbH Revenue Growth Rate in Restless Legs Syndrome Business (2021–2026)
Figure 48. UCB SA Revenue Growth Rate in Restless Legs Syndrome Business (2021–2026)
Figure 49. Astellas Revenue Growth Rate in Restless Legs Syndrome Business (2021–2026)
Figure 50. Arbor Pharmaceuticals Revenue Growth Rate in Restless Legs Syndrome Business (2021–2026)
Figure 51. GlaxoSmithKline plc. Revenue Growth Rate in Restless Legs Syndrome Business (2021–2026)
Figure 52. Ligand Pharmaceuticals Incorporated Revenue Growth Rate in Restless Legs Syndrome Business (2021–2026)
Figure 53. axxonis Pharma AG Revenue Growth Rate in Restless Legs Syndrome Business (2021–2026)
Figure 54. Kyowa Hakko Kirin Co. Revenue Growth Rate in Restless Legs Syndrome Business (2021–2026)
Figure 55. Jazz Pharmaceuticals, Inc. Revenue Growth Rate in Restless Legs Syndrome Business (2021–2026)
Figure 56. Omeros Corporation Revenue Growth Rate in Restless Legs Syndrome Business (2021–2026)
Figure 57. Manhattan Pharmaceuticals Revenue Growth Rate in Restless Legs Syndrome Business (2021–2026)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
